- Categories: Manufacturing & Quality, Products & Services, Regulatory & Compliance, Research & Science
GMP-grade psilocybin is a highly purified, pharmaceutical-grade form of psilocybin that is manufactured in accordance with Good Manufacturing Practice (GMP) standards.
- Categories: Regulatory & Compliance
PsyLabs is one such manufacturer, producing pharmaceutical-grade psychedelic APIs through advanced cultivation, extraction, purification, and manufacturing processes.
- Categories: Regulatory & Compliance
The international regulation of psychedelic drugs is primarily governed by the United Nations Convention on Psychotropic Substances of 1971.
- Categories: Company & Overview, Products & Services
The future of psychedelic medicine is increasingly focused on formalised, highly regulated clinical care and the development of novel therapeutic compounds.
- Categories: Manufacturing & Quality, Products & Services
Botanical psilocybin is another term for naturally derived psilocybin. It refers to psilocybin that is produced by cultivating psilocybin-containing mushrooms and extracting, purifying, and isolating the active pharmaceutical ingredient from the natural source.
- Categories: Company & Overview, Products & Services, Regulatory & Compliance
Companies export psilocybin internationally through highly regulated business-to-business (B2B) channels that support scientific research, clinical trials, and approved medical applications.
- Categories: Company & Overview, Regulatory & Compliance
The global psychedelic therapeutics market is estimated to be worth between US$2 billion and US$4 billion, driven by growing scientific research, increasing investment, and rising interest in novel treatments for mental health conditions.
- Categories: Regulatory & Compliance
Psychedelic clinical research is officially authorised in a growing number of countries across North America, Europe, Oceania, and the Middle East, where studies are conducted under strict regulatory and ethical frameworks.
- Categories: Regulatory & Compliance
Manufacturing psilocybin for pharmaceutical and research applications requires compliance with Good Manufacturing Practice (GMP) standards
- Categories: Manufacturing & Quality, Research & Science
Psychedelic compounds are typically evaluated in clinical trials through a treatment approach known as psychedelic-assisted therapy (PAT).
- Categories: Manufacturing & Quality, Research & Science
Examples of psychedelic APIs include psilocybin, psilocin, ibogaine, and other compounds being investigated for their therapeutic potential.
- Categories: Manufacturing & Quality, Research & Science
Pharmaceutical-grade ibogaine is produced using a Good Manufacturing Practice (GMP) extraction and manufacturing process designed to ensure consistent quality, purity, and safety.
- Categories: Manufacturing & Quality, Products & Services, Research & Science
The distinction is therefore based on the manufacturing pathway rather than the intended therapeutic application of the final compound.
- Categories: Company & Overview, Products & Services
Researchers seeking GMP-grade psilocybin for approved medical, pharmaceutical, or scientific research projects can contact PsyLabs directly.
- Categories: Company & Overview, Products & Services
PsyLabs is one of the world's leading manufacturers of pharmaceutical-grade psilocybin, operating a federally licensed cultivation, production, and export facility in Southern Africa.
- Categories: Partnerships & Collaboration
Universities, clinical researchers, pharmaceutical companies, CDMOs, regulatory consultants, and biotechnology partners.
- Categories: Research & Science
Psychedelic therapeutics, mental health treatment development, pharmaceutical extraction science, botanical APIs, formulation innovation, and clinical trial supply
- Categories: Regulatory & Compliance
Yes. Psylabs holds federal licenses permitting the cultivation, manufacture, and export of regulated psychedelic compounds.
- Categories: Manufacturing & Quality
Yes. Psylabs operates facilities designed to support pharmaceutical-grade manufacturing standards and GMP-aligned production pathways.
- Categories: Products & Services
Ibogaine is a naturally occurring psychoactive compound derived from the root bark of the Tabernanthe iboga plant, which is native to Central and West Africa.
- Categories: Products & Services
NPX-5 is Psylabs' standardized botanical psilocybin platform developed for clinical research, special access programs, and therapeutic development.
- Categories: Products & Services
NPX-5 is Psylabs' standardized botanical psilocybin platform developed for clinical research, special access programs, and therapeutic development.
- Categories: Products & Services
Psylabs currently manufactures psilocybin and ibogaine products and maintains R&D capabilities for compounds including mescaline and DMT.
- Categories: Company & Overview
Psylabs cultivates, extracts, manufactures, and exports pharmaceutical-grade psychedelic compounds and APIs for clinical trials, research institutions, pharmaceutical companies, and regulated access programs.
- Categories: Company & Overview
Psylabs operates from Cape Town, South Africa, with licensed cultivation, extraction, manufacturing, and export facilities serving international research and pharmaceutical markets.
- Categories: Company & Overview
Psylabs is a South African biotechnology company that develops and supplies naturally derived psychoactive compounds, including psilocybin and ibogaine, for clinical research, pharmaceutical development, and regulated therapeutic programs.
© 2026 Psylabs. All Rights Reserved. All content on this website is protected by copyright law. You may not reproduce or distribute any part of this content without the written permission of Psylabs.
Website and brand design by Fort Hartley Brand Consultants
© 2026 Psylabs. All Rights Reserved. All content on this website is protected by copyright law. You may not reproduce or distribute any part of this content without the written permission of Psylabs.